Longeveron Company

We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Through patient-focused, regenerative medicine, our research and therapies are aimed at improving healthspan.

Funding Status: IPO
Headquarters: Miami
Founded Date: 2014
Employee Number: 20
Last Funding Type: Grant
Total Funding: 8.99997
Estimated Revenue: $1M to $10M
Industry: Cellular therapy
Investors Number: 3
Technology: Regenerative Medicine
Investor Type: For Profit
Number Of Exists: 11-50